11-hydroxyandrostenedione has been researched along with Adrenal Cortex Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukami, M; Hasegawa, T; Hayashi, M; Homma, K; Kataoka, Y; Kato, F; Ogata, T; Oiso, Y; Sasano, H; Sugimura, Y; Tanaka, H | 1 |
1 other study(ies) available for 11-hydroxyandrostenedione and Adrenal Cortex Cancer
| Article | Year |
|---|---|
A 68-year-old phenotypically male patient with 21-hydroxylase deficiency and concomitant adrenocortical neoplasm producing testosterone and cortisol.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Aged; Androstenedione; Base Sequence; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydrocortisone; Immunohistochemistry; Japan; Magnetic Resonance Imaging; Male; Molecular Sequence Data; Pregnanetriol; Sequence Analysis, DNA; Testosterone | 2013 |